Chemclin Diagnostics: Shanghai Peixi and its concerted parties have completed a reduction of 3% of their shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Chemclin Diagnostics announced that from November 4, 2024, to December 18, 2024, Shanghai Peixi and its concerted party HJ CAPITAL cumulatively reduced their holdings of the company's shares by 12.0332 million shares, accounting for 3% of the company's total share capital. This reduction plan has been completed
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments